logo

DRUG

Bright Minds·NASDAQ
--
--(--)
--
--(--)

DRUG fundamentals

Bright Minds (DRUG) released its earnings on Aug 11, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.2918 (YoY --), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.2918
--
Report date
Aug 11, 2025
EPS
Q2,2022
Q3,2022
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,2024
Q1,2025
Q2,2025
Actual
-1.5185-0.8541-0.12560.0069-0.2918
Forecast
-0.4434-0.0156-0.3013
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+71.67%
+144.23%
+3.15%
Revenue
Q2,2022
Q3,2022
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,2024
Q1,2025
Q2,2025
Actual
------------------000
Forecast
--------------------00
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Earnings Call